These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 6088042

  • 1. Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22.
    Papsidero LD, Nemoto T, Croghan GA, Chu TM.
    Cancer Res; 1984 Oct; 44(10):4653-7. PubMed ID: 6088042
    [Abstract] [Full Text] [Related]

  • 2. Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22.
    Croghan GA, Papsidero LD, Valenzuela LA, Nemoto T, Penetrante R, Chu TM.
    Cancer Res; 1983 Oct; 43(10):4980-8. PubMed ID: 6349797
    [Abstract] [Full Text] [Related]

  • 3. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR, Koda JE, Gaur PK.
    Cancer Res; 1987 Nov 15; 47(22):5853-60. PubMed ID: 2444335
    [Abstract] [Full Text] [Related]

  • 4. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
    Pancino GF, Le Doussal V, Mortada MH, Berthon P, Osinaga E, Calvo F, Roseto A.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7078-85. PubMed ID: 2555058
    [Abstract] [Full Text] [Related]

  • 5. Elevated levels of a high molecular weight antigen detected by antibody W1 in sera from breast cancer patients.
    Linsley PS, Ochs V, Laska S, Horn D, Ring DB, Frankel AE, Brown JP.
    Cancer Res; 1986 Oct 15; 46(10):5444-50. PubMed ID: 2428478
    [Abstract] [Full Text] [Related]

  • 6. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer.
    Iacobelli S, Arnò E, D'Orazio A, Coletti G.
    Cancer Res; 1986 Jun 15; 46(6):3005-10. PubMed ID: 3516389
    [Abstract] [Full Text] [Related]

  • 7. MAM-6 antigen, a new serum marker for breast cancer monitoring.
    Hilkens J, Kroezen V, Bonfrer JM, De Jong-Bakker M, Bruning PF.
    Cancer Res; 1986 May 15; 46(5):2582-7. PubMed ID: 3697998
    [Abstract] [Full Text] [Related]

  • 8. Immunoaffinity isolation of ductal carcinoma antigen using monoclonal antibody F36/22.
    Papsidero LD, Croghan GA, Johnson EA, Chu TM.
    Mol Immunol; 1984 Oct 15; 21(10):955-60. PubMed ID: 6095073
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma.
    Papsidero LD, Croghan GA, O'Connell MJ, Valenzuela LA, Nemoto T, Chu TM.
    Cancer Res; 1983 Apr 15; 43(4):1741-7. PubMed ID: 6339043
    [Abstract] [Full Text] [Related]

  • 10. Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.
    Stacker SA, Thompson CH, Sacks NP, Tjandra J, Lowe MG, Bishop J, McKenzie IF.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7060-6. PubMed ID: 3191482
    [Abstract] [Full Text] [Related]

  • 11. Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancer.
    Stacker SA, Thompson CH, Lowe MG, Sacks NP, Golder J, Carmen H, McKenzie IF.
    Dev Biol Stand; 1987 Dec 15; 67():91-6. PubMed ID: 3609486
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies.
    Dell'Erba L, Calo-Gabrieli G, Caruso ML, Thomas R, Cortino G, Valentini AM, Muto P, Albrizio M, Pastena MI, Lastoria S.
    Anticancer Res; 2001 Dec 15; 21(2A):925-30. PubMed ID: 11396186
    [Abstract] [Full Text] [Related]

  • 13. Biochemical and immunochemical analysis of a breast carcinoma associated antigen defined by the monoclonal antibody NCRC-11.
    Price MR.
    Arch Geschwulstforsch; 1987 Dec 15; 57(3):177-80. PubMed ID: 2441681
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
    Frierson HF.
    Mod Pathol; 1993 May 15; 6(3):290-4. PubMed ID: 8102204
    [Abstract] [Full Text] [Related]

  • 15. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine.
    Kannagi R, Fukushi Y, Tachikawa T, Noda A, Shin S, Shigeta K, Hiraiwa N, Fukuda Y, Inamoto T, Hakomori S.
    Cancer Res; 1986 May 15; 46(5):2619-26. PubMed ID: 3008996
    [Abstract] [Full Text] [Related]

  • 16. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L, Sarcević B, Malenica B, Novak D.
    Neoplasma; 1993 May 15; 40(2):69-74. PubMed ID: 8394515
    [Abstract] [Full Text] [Related]

  • 17. [Expression of T and Tn antigens in breast cancers].
    Konska G, Favy D, Guillot J, Bernard-Gallon D, de Latour M, Fonck Y.
    C R Seances Soc Biol Fil; 1998 May 15; 192(4):733-47. PubMed ID: 9842474
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal antibody PR92 with restricted specificity for tumor-associated antigen of prostate and breast carcinoma.
    Kim YD, Robinson DY, Tomita JT.
    Cancer Res; 1988 Aug 15; 48(16):4543-8. PubMed ID: 3396007
    [Abstract] [Full Text] [Related]

  • 19. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ, Neaman IE, Elting JJ, Barnett TR, Yoshimura H, Fritsche HA, Yeung KK.
    Cancer Res; 1994 Mar 01; 54(5):1227-34. PubMed ID: 8118811
    [Abstract] [Full Text] [Related]

  • 20. Immunoperoxidase localization of a high-molecular-weight mucin recognized by monoclonal antibody 1D3.
    Gangopadhyay A, Bhattacharya M, Chatterjee SK, Barlow JJ, Tsukada Y.
    Cancer Res; 1985 Apr 01; 45(4):1744-52. PubMed ID: 3884144
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.